| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Experience Officer
1 company
Hakan Kardes last filed a Form 4 in March 2025, as Chief Experience Officer at ALHC. Hakan Kardes's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Hakan Kardes a below-average insider score of 40/100, based on 15 past trades. Over a 12-month horizon, 6.7% of those trades were profitable, with an average 12-month return of -42.5%.
At the last filing, the largest reported position was 678,987 shares of ALHC. The ALHC filings lean toward selling, a net 292,995 shares.
Hakan Kardes has 14 Form 4 filings on record from March 2024 to March 2025, all as Chief Experience Officer at Alignment Healthcare (ALHC), 2024–2025.
The 20 reported transactions were 17 open-market sales and 3 stock awards.
Counted by filing, the open-market trades come to no purchases and 13 sales worth about $3.9M.
The largest open-market sale was 86,659 shares of ALHC at an average $15.53 on March 6, 2025, about $1.3M. Twelve months later ALHC was up 21%.
6 of the 13 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 7 were not.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell | 7,225 | $17.89 | $129,255.25 | -1.1% | -24.4% | -8.3% | |
| Mar 19, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 31,602 | $16.88 | $533,471.88 | -4.4% | -15.2% | +5.6% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell | 4,856 | $15.43 | $74,916.29 | -0.7% | -6.7% | +9.0% | |
| Mar 6, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell | 86,659 | $15.53 | $1,345,814.27 | -11.3% | +0.5% | +20.9% | |
| Jan 24, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 14,500 | $14.98 | $217,276.70 | -4.7% | +20.5% | +59.1% | |
| Jan 21, 2025 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 10,500 | $14.99 | $157,369.80 | -3.3% | +20.1% | +59.9% | |
| Nov 27, 2024 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell | 35,000 | $12.80 | $448,140.00 | -9.8% | +4.4% | +49.7% | |
| Nov 4, 2024 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 25,000 | $13.04 | $326,112.40 | -6.6% | +15.7% | +28.6% | |
| Sep 12, 2024 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 25,000 | $11.48 | $287,052.50 | -6.2% | +1.3% | +38.5% | |
| Jul 16, 2024 | ALHC Alignment Healthcare, Inc. | Chief Experience Officer | Sell10b5-1 | 25,000 | $9.98 | $249,500.00 | -5.8% | +15.4% | +35.7% |